Mitral Regurgitation

As per available reports about 135 journals, 58 Conferences, 10 workshops are presently dedicated exclusively to Mitral Regurgitation and about 18,100 articles are being published on the current trends in Mitral Regurgitation. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to Mitral Regurgitation are being carried out. Mitral regurgitation is defined as an abnormal reversal of blood flow from the left ventricle to the left atrium. It is caused by disruption in any part of the mitral valve apparatus. The most common etiologies of Mitral regurgitati include mitral valve prolapse, rheumatic heart disease, infective endocarditis, annular calcification, cardiomyopathy, and ischemic heart disease.

The  Journal of Clinical & Experimental Cardiology is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in Mitral Regurgitation. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Clinical & Experimental Cardiology provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of Mitral Regurgitation, thus bridging the gap between researchers and young scientists.

OMICS International – a pioneer in organizing international conferences: Cardiology International conference is designed to provide diverse and current education that will keep medical professionals abreast of the issues affecting the prevention, diagnosis and treatment of cardiovascular disease. This three-day Cardiology conference is renowned for its close interactions between faculty and learners. A comprehensive overview of current problems in cardiovascular medicine and surgery is combined with a focused symposia, workshops and lecture presentations. Distinguished faculty will lead discussions on a variety of issues facing today’s cardiovascular providers such as Pediatric Heart Diseases, Cardiomyopathy, Angiogenesis, Pacemakers, Cardiac Rehabilitation, Statin Therapy, Pulmonary Stenosis, Atrial Fibrillation and Electrocardiography. Topics range from prevention strategies to the latest in lipid and hypertension guidelines, GI disease, PAD, Heart diseases, and mitral & aortic valve disease. Researchers in our meetings will emphasize incorporating best practices and quality, including practical application of practice guidelines, into care.